Log your weight with a few taps and view your progress over time with easy-to-read charts
Clinical studies have shown remarkable outcomes, positioning retatrutide as a superior peptide for obesity and weight management research
The proportion of patients achieving NASH resolution in the absence of fibrosis progression was 40%, 36%, and 59% for the 0.1, 0.2, and 0.4 mg semaglutide arms, respectively, whereas the corresponding rate in the placebo arm was 17% ( Notably, based on the results from part 1 of the ESSENCE trial, on 15 August 2025, the FDA approved semaglutide 2.4 mg for the treatment of adults with MASH with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis)
Commonly considered an undesirable off-target for molecular glue degrader programs, GSPT1 is emerging as a promising oncology target
It can show up as a snacky feeling, so we go look in the cupboard or fridge for something to eat even though our brain is asking for water, Salamon says
In addition to these serious side effects, Contrave may also cause seizures, liver problems, and visual problems
